Literature DB >> 16353668

Steroidogenic factor 1 gene transcription is inhibited by transforming growth factor beta.

Tomasz P Lehmann1, Justyna M Biernacka-Lukanty, Wieslaw H Trzeciak, Jacques Y Li.   

Abstract

The orphan nuclear receptor, steroidogenic factor 1 (SF-1), plays a major role in adrenal and gonadal development, as well as in sexual differentiation. It has been demonstrated that the expression of a number of genes regulated by SF-1 is inhibited by the transforming growth factor, (TGF-beta). To date, however, the influence of TGF-beta on the expression of SF-1 gene has not been reported. A Northern blot analysis with the use of a radiolabeled cDNA probe, and immunodetection with antibodies directed against SF-1, demonstrated that the Sf-1 transcript and the SF-1 protein levels were lowered by TGF-beta in Y-1 adrenocortical cells, both in untreated and adenylyl cyclase activator, forskolin-treated cells. An examination of the Sf-1 transcript stability in the presence of actinomycin D revealed no influence of TGF-beta on the rate of Sf-1 mRNA decay. Inhibition of Sf-1 expression by TGF-beta was abolished by cycloheximide, suggesting that the growth factor inhibitory effect requires ongoing protein synthesis. We conclude that in Y-1 cells TGF-beta inhibits the expression of SF-1 gene at a transcriptional level, and we postulate that the inhibitory effect of TGF-beta on steroid hormone synthesis in the adrenal cortex could be due to an attenuated transcription of Sf-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353668     DOI: 10.1080/07435800500229110

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  8 in total

Review 1.  Transforming growth factor beta1 and aldosterone.

Authors:  Kota Matsuki; Catherine K Hathaway; Albert S Chang; Oliver Smithies; Masao Kakoki
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

Review 2.  Transforming growth factor-β1 and diabetic nephropathy.

Authors:  Albert S Chang; Catherine K Hathaway; Oliver Smithies; Masao Kakoki
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

Review 3.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

4.  The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas.

Authors:  E Harman; M Karadeniz; C Biray; A Zengi; S Cetinkalp; A G Ozgen; F Saygili; A Berdeli; C Gündüz; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2009-05-12       Impact factor: 4.256

5.  SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells.

Authors:  Natalia Derebecka-Holysz; Tomasz P Lehmann; Marcin Holysz; Wieslaw H Trzeciak
Journal:  Mol Cell Biochem       Date:  2007-09-05       Impact factor: 3.396

6.  Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.

Authors:  Anna Ehrlund; Philip Jonsson; Lise-Lotte Vedin; Cecilia Williams; Jan-Åke Gustafsson; Eckardt Treuter
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

7.  TGF-β1 regulation of estrogen production in mature rat Leydig cells.

Authors:  Man-Li Liu; Huan Wang; Zong-Ren Wang; Yu-Fen Zhang; Yan-Qiu Chen; Fang-Hong Zhu; Yuan-Qiang Zhang; Jing Ma; Zhen Li
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

8.  Range of SHH signaling in adrenal gland is limited by membrane contact to cells with primary cilia.

Authors:  Ivona Mateska; Kareena Nanda; Natalie A Dye; Vasileia Ismini Alexaki; Suzanne Eaton
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.